Jinmin Li

Title: Jinmin Li - Innovator in Biotechnology

Introduction

Jinmin Li is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly through his innovative work on phospholipase C mutants. His research has the potential to impact various applications in the life sciences.

Latest Patents

Jinmin Li holds a patent for a "Phospholipase C mutant and use thereof." This patent describes mutants of wild type phospholipase C (PLC) that are specific to phosphatidylcholine. The related mutations include the alteration of asparagine at position 63 to another amino acid, the mutation of arginine at position 20 to histidine, and the mutation of alanine at position 83 to aspartic acid. The application also provides a nucleic acid molecule encoding the mutant, a vector containing the nucleic acid molecule, and a cell that includes the nucleic acid molecule or vector. Furthermore, it outlines various uses for the mutant, nucleic acid molecule, vector, and cell.

Career Highlights

Jinmin Li is associated with Wilmar (Shanghai) Biotechnology Research & Development Center Co., Ltd. His work at this esteemed institution has allowed him to explore and develop groundbreaking biotechnological innovations. With a focus on enhancing the functionality of phospholipase C, he has positioned himself as a key figure in the field.

Collaborations

Jinmin Li collaborates with notable colleagues such as Jun Xu and Yaoji Xuan. Their combined expertise fosters a productive research environment that drives innovation and discovery in biotechnology.

Conclusion

Jinmin Li's contributions to biotechnology, particularly through his patent on phospholipase C mutants, highlight his role as an influential inventor. His work continues to pave the way for advancements in the field, showcasing the importance of innovation in scientific research.